Riverside Methodist Hospital to deploy McKesson IV automation solution
McKesson claims the CytoCare is the only proven automation solution for compounding hazardous IVs used for chemotherapy and monoclonal antibody therapy. The new technology will enable the 800-bed
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.